Mutual Funds

Tata India Pharma & Healthcare Fund-Reg(G)
Equity | Very High | Equity - Sectoral Fund - Pharma & Health Care

33.43 -0.16
NAV(₹) as on 4/9/2026

-0.49%
1D

8.54%
1Y

18.94%
3Y

12.92%
5Y

Tata India Pharma & Healthcare Fund-Reg(G)
Growth Chart of the Scheme

Scheme Details
Expense Ratio: 2.28	Launch Date: 28 Dec 2015
Exit Load: 0.25% on or before 30D	AUM: ₹ 1,541.42 Crs
Lock-in: Nil	Investing Style: Mid Growth
Portfolio Price To Book Value: 8.40	Min. Investment: SIP : ₹ 100.00 Lumpsum : ₹ 5,000.00
Scheme Benchmark: NA
Fund Manager: Rajat Srivastava

FUND OBJECTIVE

Investment objective of the scheme is to provide long term capital appreciation by investing predominantly in equity/equity related instruments of the companies in the Pharma&Healthcare sectors in India. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.

LATEST ASSET & PORTFOLIO ALLOCATION		Others		Equity
as on 31/7/2026		0.86 %		99.14 %

TOP HOLDINGS

Sun Pharmaceutical Industries Ltd.

8.59 %

Divi's Laboratories Ltd.

6.36 %

Healthcare Global Enterprises Ltd.

5.85 %

Abbott India Ltd.

5.63 %

Rainbow Children's Medicare Ltd.

4.90 %

Glaxosmithkline Pharmaceuticals Ltd.

4.66 %

Cipla Ltd.

4.53 %

Dr. Reddy's Laboratories Ltd.

4.25 %

Max Healthcare Institute Ltd.

4.07 %

Apollo Hospitals Enterprise Ltd.

3.90 %

See All Holding

ALLOCATION BY MARKET CAP (Equity)

ALLOCATION BY RATING (Debt & Others)

No Data

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs

60.30 %

Hospital & Healthcare Servic

28.92 %

Pesticides & Agrochemicals

4.85 %

Business Support

2.95 %

Household & Personal Product

1.15 %

See All Sectors

PORTFOLIO CHARACTERISTICS (Debt)

No Data

5 YEAR HISTORY

Financial Year	2021-22	2022-23	2023-24	2024-25	2025-26
NAV (31/3/2026)	17.18	15.88	25.06	28.64	28.10
Net Assets (Rs Crores)	55,332.96	49,343.66	87,870.28	1,18,365.32	1,22,942.18
Scheme Returns(%)(Absolute)	16.04	-7.31	57.46	13.01	-0.81
B'mark Returns(%)(Absolute)	NA	NA	NA	NA	NA
Category Rank	41/75	67/76	19/90	20/102	51/120

RISKOMETER
Level of Risk in the Scheme

Clients will understand that their principal will be at Very High risk.

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Fund Details	Inception Date	Aum(₹ Crs)	1Y	3Y	5Y	Since Inception
Kotak Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 16.91 +-0.06	11/12/2023	₹ 682.39	25.21%	-	-	21.17%
HDFC Pharma and Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 21.64 +-0.08	4/10/2023	₹ 2,939.98	25.51%	-	-	30.42%
WOC Pharma and Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 16.78 +-0.11	6/2/2024	₹ 824.9	19.97%	-	-	22.24%
PGIM India Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 12.10 +-0.10	6/12/2024	₹ 111.64	22.47%	-	-	11.54%
Bajaj Finserv Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 11.80 +-0.06	27/12/2024	₹ 376.77	19.98%	-	-	10.28%
Baroda BNP Paribas Health and Wellness Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 10.67 +-0.07	27/6/2025	₹ 519.48	9.09%	-	-	5.62%
Bandhan Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 11.22 +-0.03	28/11/2025	₹ 319.48	-	-	-	12.23%
ITI Pharma & Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 18.04 +-0.11	8/11/2021	₹ 262.84	11.09%	18.29%	-	13.01%
Nippon India Pharma Fund(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 570.74 +-3.30	5/6/2004	₹ 9,279.11	10.69%	18.29%	12.52%	19.92%
Tata India Pharma & Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 33.43 +-0.16	28/12/2015	₹ 1,541.42	8.54%	18.94%	12.92%	11.95%